Magnesium Monoethylfumarate

Adenosinum Cyclophosphoricum, Alumina, Arsenicum Album, Cerium Oxalicum, Cobalt Gluconate, Cuprum Sulphuricum, Calcarea Phosphorica, Chromium Metallicum, Cobaltum Metallicum, Cuprum Metallicum, Ferrum Metallicum, Iodium, Iridium Metallicum, Kali Carbonicum, Lithium Carbonicum, Magnesium Metallicum, Manganum Metallicum, Molybdenum, Natrum Muriaticum, Phosphorus, Selenium Metallicum, Strontium Carbonicum, Sulphur, Vanadium Metallicum, Zincum Metallicum, Aluminium Metallicum, Antimonium Crudum,

adenosinum cyclophosphoricum, alumina, arsenicum album, cerium oxalicum, cobalt gluconate, cuprum sulphuricum, calcarea phosphorica, chromium metallicum, cobaltum metallicum, cuprum metallicum, ferrum metallicum, iodium, iridium metallicum, kali carbonicum, lithium carbonicum, magnesium metallicum, manganum metallicum, molybdenum, natrum muriaticum, phosphorus, selenium metallicum, strontium carbonicum, sulphur, vanadium metallicum, zincum metallicum, aluminium metallicum, antimonium crudum,

Vitamin D [EPC]

PURPOSE: Adenosinum Cyclophosphoricum - Fatigue, Alumina – Crampy Pain, Aluminium Metallicum - Nervousness, Antimonium Crudum - Fatigue, Argentum Metallicum - Nervousness, Arsenicum Album – Crampy Pain, Aurum Metallicum - Fatigue, Baryta Carbonica - Nervousness, Beryllium Metallicum – Crampy Pain, Bismuthum Metallicum - Fatigue, Bromium - Nervousness, Cadmium Metallicum – Crampy Pain, Calcarea Phosphorica - Fatigue, Cerium Metallicum - Nervousness, Cerium Oxalicum – Crampy Pain, Cesium Chloride

Coagulation Factor X Human

coagulation factor x human

11 DESCRIPTION COAGADEX is a plasma-derived, sterile, purified concentrate of human coagulation Factor X that contains sucrose as a stabilizer. It is formulated as a lyophilized powder for solution for intravenous administration. When reconstituted with Sterile Water for Injection it forms a colorless, clear or slightly pearl-like solution.

Azilsartan Kamedoxomil

azilsartan kamedoxomil

11 DESCRIPTION Edarbi (azilsartan medoxomil), a prodrug, is hydrolyzed to azilsartan in the gastrointestinal tract during absorption. Azilsartan is an angiotensin II receptor blocker. The drug substance used in the drug product formulation is the potassium salt of azilsartan medoxomil, also known by the US accepted name of azilsartan kamedoxomil and is chemically described as (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1 H.